UK markets open in 7 hours 16 minutes

Core Laboratories N.V. (0Q82.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
18.40-1.60 (-8.00%)
At close: 09:35AM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.63
52-week change 3N/A
S&P500 52-week change 3-10.86%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 846.13M
% held by insiders 10.52%
% held by institutions 1108.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.04
Trailing annual dividend yield 30.20%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 3.16%
Operating margin (ttm)8.35%

Management effectiveness

Return on assets (ttm)4.39%
Return on equity (ttm)9.15%

Income statement

Revenue (ttm)487.3M
Revenue per share (ttm)10.52
Quarterly revenue growth (yoy)6.80%
Gross profit (ttm)102.36M
EBITDA 58.15M
Net income avi to common (ttm)15.39M
Diluted EPS (ttm)0.19
Quarterly earnings growth (yoy)760.90%

Balance sheet

Total cash (mrq)13.73M
Total cash per share (mrq)0.3
Total debt (mrq)236.12M
Total debt/equity (mrq)128.82
Current ratio (mrq)2.23
Book value per share (mrq)3.85

Cash flow statement

Operating cash flow (ttm)18.9M
Levered free cash flow (ttm)14.67M